title: Why using Avastin for eye disease is so difficult.
authors.affiliation: ingrid_torjesen@hotmail.com
authors.forename: Ingrid
authors.initials: I
authors.lastname: Torjesen
mesh_terms: D020533:Angiogenesis Inhibitors / Q000191:economics / Q000627:therapeutic use*; D061067:Antibodies, Monoclonal, Humanized / Q000191:economics / Q000627:therapeutic use*; D000068258:Bevacizumab; D016527:Drug Costs; D004345:Drug Industry / Q000191:economics* / Q000331:legislation & jurisprudence; D006801:Humans; D008268:Macular Degeneration / Q000188:drug therapy*; D040541:Marketing / Q000191:economics; D056687:Off-Label Use / Q000191:economics / Q000331:legislation & jurisprudence; D000069579:Ranibizumab; D006113:United Kingdom
chemical_list: D020533:Angiogenesis Inhibitors; D061067:Antibodies, Monoclonal, Humanized; D000068258:Bevacizumab; D000069579:Ranibizumab